This article, published in The Lancet, argues that there is a moral imperative to make vaccines widely available on an equitable basis. The authors lay out a call to action for the new decade of vaccines, which embraces four key elements. …

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

This comprehensive manual deals with a wide range of scientific and clinical issues relating to child, adult, and traveler immunization. Information is provided on vaccine safety, immunization recommendations, and specific vaccines and diseases.

This interactive tool is designed for public health officials seeking guidance and resources related to developing evidence-based cervical cancer prevention programs in their countries. It includes video mini-lectures and other films, impact models, …

This report provides an in-depth look at PATH's work on cervical cancer prevention over the past two decades. It includes background on cervical cancer and HPV, and details about its work in four key areas: HPV vaccination, innovative approaches to …

The authors of this article, which is a chapter in a monograph published in Vaccine, argue that HPV vaccine should be introduced in the framework of comprehensive cervical cancer control, and offers an opportunity to bring together a wide range of …

This article, published in the New England Journal of Medicine, offers a comprehensive review of virologic, epidemiologic, and clinical data on influenza A(H1N1) virus infections during the 2009 pandemic and summarizes key issues for clinicians …

This fact sheet provides information on cold chain and logistics for vaccine delivery, including challenges for managing the cold chain, examples of effective cold chain management, and the costs associated with the cold chain.

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. …

This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life …

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Published in the Bulletin of the World Health Organization, this paper offers the first attempt to quantitatively evaluate the supportive supervision framework in Andhra Pradesh, India.

This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …

This issue brief discusses how ensuring swift and efficient HPV vaccine introduction in developing countries will not only help address the burden of cervical cancer, but will also provide a valuable opportunity for AIDS vaccine researchers and …

This website provides information about the DoV Collaboration which was launched in 2010 to enhance coordination across the global community by bringing together diverse stakeholders to develop an evidence-based, country-led global vaccine action …

This report highlights new partnerships and innovations in cervical cancer prevention and treatment. It also provides profiles of success in increasing access to HPV vaccines and treatment from around the world, with country spotlights on Mexico, …

Facilitated by project Optimize and conducted by a multidisciplinary group of partners, these landscape analyses highlight ongoing work related to five priority areas that comprise the vision for immunization supply systems in 2020. The analyses …

This article, which appeared in the Old Herborn University Seminar Monograph, provides a summary of the discussions at a workshop hosted by the Old Herborn University Foundation in June 2010. The discussions were held to examine the …

A comprehensive global health examination, this book contributes substantially to global initiatives to improve the health of all peoples by providing a multidisciplinary understanding of fundamental issues and challenges, as well as effective …

The Effective Vaccine Management (EVM) initiative provides materials and tools needed to monitor and assess vaccine supply chains and help countries to improve their supply chain performance. This web page provides links to EVM background and …

In 2010, Burkina Faso conducted a country-wide campaign to introduce a new Group A meningococcal conjugate vaccine, MenAfriVac™. Leading up to this effort, the following challenges were successfully managed: (1) conducting a large safety study …

This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in …

Routine immunization of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May 1997. This article, published in The Lancet, reports on a study that investigated the effectiveness …

This article, published in the Bulletin of the World Health Organization, describes avenues for service delivery of human papillomavirus (HPV) vaccines and critical information gaps that must be bridged in order to inform future sexual and …